NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Recruiting · NCT06889766 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2026-05-15 | NCT06889766 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire Vaudois | 62 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | 11 |
| Centre Hospitalier Universitaire Vaudois (CHUV) | Lausanne | Switzerland | 15 |